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Molecular diagnostic and genetic characterization of highly pathogenic viruses: application
during Crimean–Congo haemorrhagic fever virus outbreaks in Eastern Europe and the Middle
East
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Abstract
Several haemorrhagic fevers are caused by highly pathogenic viruses that must be handled in Biosafety level 4 (BSL–4) containment. These
zoonotic infections have an important impact on public health and the development of a rapid and differential diagnosis in case of outbreak in
risk areas represents a critical priority. We have demonstrated the potential of a DNA resequencing microarray (PathogenID v2.0) for this
purpose. The microarray was ﬁrst validated in vitro using supernatants of cells infected with prototype strains from ﬁve different families of
BSL-4 viruses (e.g. families Arenaviridae, Bunyaviridae, Filoviridae, Flaviviridae and Paramyxoviridae). RNA was ampliﬁed based on isothermal
ampliﬁcation by Phi29 polymerase before hybridization. We were able to detect and characterize Nipah virus and Crimean–Congo
haemorrhagic fever virus (CCHFV) in the brains of experimentally infected animals. CCHFV was ﬁnally used as a paradigm for epidemics
because of recent outbreaks in Turkey, Kosovo and Iran. Viral variants present in human sera were characterized by BLASTN analysis.
Sensitivity was estimated to be 105–106 PFU/mL of hybridized cDNA. Detection speciﬁcity was limited to viral sequences having ∼13–14%
of global divergence with the tiled sequence, or stretches of ∼20 identical nucleotides. These results highlight the beneﬁts of using the
PathogenID v2.0 resequencing microarray to characterize geographical variants in the follow-up of haemorrhagic fever epidemics; to manage
patients and protect communities; and in cases of bioterrorism.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
ONLINE–ONLY ORIGINAL ARTICLE VIROLOGY
